Share Name Share Symbol Market Type Share ISIN Share Description
Scancell Hldgs LSE:SCLP London Ordinary Share GB00B63D3314 ORD 0.1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.55p +4.55% 12.65p 12.30p 13.00p 12.75p 12.35p 12.50p 1,759,039 14:32:07
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 0.0 -4.5 -1.4 - 39.48

Scancell Hldgs Share Discussion Threads

Showing 18151 to 18170 of 18175 messages
Chat Pages: 727  726  725  724  723  722  721  720  719  718  717  716  Older
DateSubjectAuthorDiscuss
22/4/2018
05:23
Around 3 mins 40 secs on the latest CH ProActive YouTube - a little slip by CH but shows the CH mindset - ''a research collaboration WITH a commercial option'' which 'will' whoops 'may' be taken up. BioNTech now have the Scientists in the World ranked second for 'intimacy with Moditope'. Sounds odd - someone will or may put it better ! Just a hunch that a lot more may come out of this collaboration, given Genentech and Roche hanging around just off stage . . . . and :- Areas of deployment of Scancell science and 'platforms' ? We have :- Immunobody Immunobody combo with Checkpoint Inhibitor (or something else). Moditope Moditope epitopes in BioNTech TCR and Glycolipid Looks like a bargain pack of science, mostly under Patents, at 12.65 pence ! Just trying to raise the tone a little. If you Guys really want a good read, swot up on Inan's brilliant posts on the science and status over the last few days. ATB
torquayfan
22/4/2018
02:53
panama7, ............""".Chelsea, you have been writing the same nonsense for 5 years, Given that, a stupid question. RG has left the Company, the Second World War finished in 1945, anything else i can help you with?
chelsea35
21/4/2018
21:54
Chelsea, you have been writing the same nonsense for 5 years, you could cut and paste hundreds of your posts over the last 5 years and none of them have come to fruition. You talk of inflection points, how many inflection points have we passed in the last 5 years with no upward movement in the share price and no reaction to any inflection points by Big Pharma. Goodfellow has taken you for a mug, he has left you out of pocket for 5 years and shown with his actions and deeds he couldn't care less about your circumstances or when you might be in a position to sell at a profit. Answer 1 question If your circumstances changed tomorrow and you were in urgent need of funds would you be happy with your investment and happy to sell at 12p.
panama7
21/4/2018
18:32
Lozan, I do not believe in the buy/hold scenario, i just have never had the shares i have now to take some profit. Would appreciate you not suggesting the contrary. Glad to see we have the £11m in cash now to take this forward. Both SCIB Combo trials are ready at a cost to Scancell of about £5m more. Not so sure it will be that long before we see the highs we have seen recently either. There are many inflection points to look forward too. in the coming months. Key is commercial deals for Moditope to take them into trials, but we have never had the cash we have now to take us forward in all platforms. Another platform too, and as we have seen recently Lindy is ensuring that whatever new technologies there are are in our.armoury. With the share price at 12p and £11m in the bank, there is every reason to look forward to the coming year IMHO, GL all those who can afford to take advantage of such an share price again. The elephant has left the room, but i am sure certain posters here would suggest it has not. Lets see how the share price performs from now, i feel very confident of a very healthy return, and if we can replicate or even improve on SCIB1 trial data, delighted we could have a wonderful treatment for cancer sufferers.
chelsea35
21/4/2018
16:39
The well informed believes another placing will take place within 12 months. Probably in America.
agema
21/4/2018
16:32
RH, if the science is as good as we are all being led to believe then this has been an incredibly poorly managed Company for 5 years. So many statements that haven't materialised having a detrimental effect on the share price every time they fail to deliver. The BOD have made so many statements that just don't stand up. They have stated on several occasions that Big Pharma want everything for nothing what an absolutely ridiculous statement to make in an industry that has seen 10's of Billions of USD change hands. All we as Investors get is excuses , they have shown Investors no respect whatsoever bearing in mind they have left many Investors out of pocket for 5 years and have shown absolutely no urgency to get those Investors money back and in fact have done the complete opposite by continually making statements and taking actions that undermine the share price I personally have some faith in the science but no faith in the BOD whatsoever.
panama7
21/4/2018
16:21
Panama, what’s your thoughts going forward? If the science isn’t good then there is no hope but I don’t believe that is the scenario here. I think someone mentioned it the other day that now we have cash to move the plan forward the board better be out there promoting the company. For too long they’ve put their trust in the science which is fine but I just don’t think maybe until recently the company has been getting into the right circles and recognised enough on the stage that we desire. The CRUK challenge has definitely changed that along with the BioNtech deal but too late in the day to alleviate the funding issue which has now been partly resolved.
rhatton
21/4/2018
15:56
NO 'c' Tide's out
the real lozan
21/4/2018
15:55
Apparently, there is a rather 'shady SPIV' 'flogging deckchair rentals' on Inanacombe prom, trying to sell 'season tickets' to watch Torquay Utd - next season. HE CLAIMS, one Lionel Messi, is to spend next season playing for Torquat Utd - on loan, urging people to 'snap-up' HIS 'season tickets' NOW, as they will be going for £6,000 each - one next seasons 'FIXture lists' are announced. . Anyone guess who HE is ???
the real lozan
21/4/2018
15:34
Panama Makes you wonder how the guy is not a billionaire by now. As he knows more than industry experts. Amazing what builders know nowadays. Perhaps that's where big pharma's are going wrong. They are not employing builders to do their research and deals. Lol.
agema
21/4/2018
15:27
Agema, the Markets, don't get, Big Pharma don't get, Goodfellow and Chiplin don't get it but the Insane one does . He really is one seriously deluded individual.
panama7
21/4/2018
13:23
inanaco quote. " Scancell pipeline now so big if not bigger than most majors. Only the market does not get it." I have heard some far out quotes in my time but that takes the biscuit.I think the Majors can buy a company for 12-13p a share.Lol.
agema
21/4/2018
08:31
Frustration often occurs when folks see = 'The WRONG people, 'get HOLD' of a GOOD idea.'
the real lozan
21/4/2018
00:50
Lozan, totally agree this BOD have no resect whatsoever for their PI's, totally arrogant , far too busy filling their own pockets at their PI's expense. what a bunch of Hunts,
panama7
20/4/2018
21:49
panama7 - think you'll find he's re-tweeted again this evening about the new platform.
gooosed
20/4/2018
19:36
REALITY - Someone picks up over 21million shares at an over 31% discount J Chips picks up 900.000 to add to his 1.1 million at an over 31% discount Existing P Is get diluted by circa 20%... BUT... They CAN BUY at the discounted price at = 1 cheap share, for every 19 not-so-cheap share ..they owned {Unlike the aforementioned} . And yet, there are some who think this is an OK situation Others might feel someone has been 'mugged'....AGAIN
the real lozan
20/4/2018
16:54
Does anyone know where Goodfellow the Mike Hunt of Aim has disappeared to, he couldn't help himself tweeting for 2 weeks prior to the fundraising. I am surprised he hasn't tweeted that it's the most successful fundraising ever and how pleased he is that his twin A.Hunt was able to support the Company in an oversubscribed fundraising by adding 900,000 shares to the 1.1m he picked up in the previously oversubscribed fundraising. what a couple of Hunts. Due to Mike Hunts' gross incompetence we now have an extra 80m shares in issue than was necessary. His lack of integrity and credibility has meant that he has had to raise at the most distressed share price levels. They raised at 22p 5 years ago for a very successful trial in an industry with Billions trading hands, so to raise at anything below 22p is sheer gross incompetence and sums up what a complete Mike Hunt he is.
panama7
20/4/2018
14:50
It's been an 'interesting' week!
supernumerary
20/4/2018
14:28
Interesting day over there!!
bermudashorts
20/4/2018
14:05
Yes, I appreciate the frustration. As so often, chronic underfunding leads to underwhelming results. Lisa doesn't know, but will get back to me...
supernumerary
Chat Pages: 727  726  725  724  723  722  721  720  719  718  717  716  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:32 V: D:20180422 06:56:42